Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Safety Assurance Case, 32964 [2014-13291]

Download as PDF 32964 Federal Register / Vol. 79, No. 110 / Monday, June 9, 2014 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 21 U.S.C. Section 393(d)(2)(D) (various data collection methods) Number of responses per respondent Number of respondents Individual Indepth Interviews ............ General Public Focus Group Interviews. Intercept Interviews: Central Location. Intercept Interviews: Telephone ........ Self-Administered Surveys ................ Gatekeeper Reviews ......................... Omnibus Surveys .............................. Total annual responses Average burden per response Total hours 360 288 1 1 360 288 0.75 (45 minutes) ............................. 1.50 (90 minutes) ............................. 270 432 200 1 200 0.25 (15 minutes) ............................. 50 4,000 2,400 400 1,200 1 1 1 1 4,000 2,400 400 1,200 0.08 0.25 0.50 0.17 (5 minutes) ............................... (15 minutes) ............................. (30 minutes) ............................. (10 minutes) ............................. 320 600 200 204 Total (General Public) ................ Physician Focus Group Interviews ... 8,848 432 1 1 8,848 432 ........................................................... 1.50 (90 minutes) ............................. 2,076 648 Total (Physician) ........................ Total (Overall) ............................ 432 9,280 ........................ 1 ........................ 9,280 ........................................................... 0.29 (17 minutes) ............................. 648 2,724 Dated: June 3, 2014. Leslie Kux, Assistant Commissioner for Policy. control number 0910–0766. The approval expires on May 31, 2017. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. [FR Doc. 2014–13292 Filed 6–6–14; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: June 3, 2014. Leslie Kux, Assistant Commissioner for Policy. Food and Drug Administration [FR Doc. 2014–13291 Filed 6–6–14; 8:45 am] BILLING CODE 4160–01–P [Docket No. FDA–2010–D–0194] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Safety Assurance Case AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Safety Assurance Case’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE–14526, Silver Spring, MD 20993–0002, PRAStaff@ fda.hhs.gov. SUMMARY: On April 10, 2014, the Agency submitted a proposed collection of information entitled ‘‘Safety Assurance Case’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB ehiers on DSK2VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 15:08 Jun 06, 2014 Jkt 232001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0736] Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee. General Function of the Committee: To provide advice and recommendations to the Agency on FDA’s regulatory issues. Date and Time: The meeting will be held on July 10 and 11, 2014, from 8 a.m. to 6 p.m. Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993– 0002. Information regarding special PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 accommodations due to a disability, visitor parking, and transportation may be accessed at: https://www.fda.gov/ AdvisoryCommittees/default.htm; under the heading ‘‘Resources for You,’’ click on ‘‘Public Meetings at the FDA White Oak Campus.’’ Please note that visitors to the White Oak Campus must enter through Building 1. Contact Person: Shanika Craig, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301–796–6639, or FDA Advisory Committee Information Line, 1–800– 741–8138 (301–443–0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency’s Web site at https:// www.fda.gov/AdvisoryCommittees/ default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting. Agenda: On July 10 and 11, 2014, the committee will discuss the safety of laparoscopic power morcellator devices as it pertains to their potential to disseminate and upstage a confined, but undetected (occult) uterine malignancy during laparoscopic hysterectomy or myomectomy. FDA is convening this committee to seek expert scientific and clinical opinion on the risks and benefits of these types of devices when used for these procedures, based on available scientific data. The committee will make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Page 32964]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-13291]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-D-0194]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Safety Assurance Case

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Safety Assurance Case'' has been 
approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, 
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver 
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On April 10, 2014, the Agency submitted a 
proposed collection of information entitled ``Safety Assurance Case'' 
to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not 
conduct or sponsor, and a person is not required to respond to, a 
collection of information unless it displays a currently valid OMB 
control number. OMB has now approved the information collection and has 
assigned OMB control number 0910-0766. The approval expires on May 31, 
2017. A copy of the supporting statement for this information 
collection is available on the Internet at https://www.reginfo.gov/public/do/PRAMain.

    Dated: June 3, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-13291 Filed 6-6-14; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.